Five‐year safety and efficacy data from a phase Ib study of nivolumab and chemotherapy in advanced non‐small‐cell lung cancer

Shintaro Kanda; Yuichiro Ohe; Yasushi Goto; Hidehito Horinouchi; Yutaka Fujiwara; Hiroshi Nokihara; Noboru Yamamoto; Takanori Yamamoto; Tomohide Tamura

doi:10.1111/cas.14410

Five‐year safety and efficacy data from a phase Ib study of nivolumab and chemotherapy in advanced non‐small‐cell lung cancer

Cancer Science ◽

10.1111/cas.14410 ◽

2020 ◽

Vol 111 (6) ◽

pp. 1933-1942

Author(s):

Shintaro Kanda ◽

Yuichiro Ohe ◽

Yasushi Goto ◽

Hidehito Horinouchi ◽

Yutaka Fujiwara ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Efficacy Data ◽

Safety And Efficacy ◽

Phase Ib

Download Full-text

ASCEND-8 pharmacokinetic, safety, and efficacy data for ceritinib 450 mg with food in patients with anaplastic lymphoma kinase–positive non-small cell lung Cancer: A clinical perspective

Cancer Treatment and Research Communications ◽

10.1016/j.ctarc.2019.100149 ◽

2019 ◽

Vol 20 ◽

pp. 100149 ◽

Cited By ~ 1

Author(s):

Salman Otoukesh ◽

Tiffany Sanchez ◽

Saied Mirshahidi ◽

Desiree Wallace ◽

Hamid Mirshahidi

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell ◽

Clinical Perspective ◽

Small Cell Lung ◽

Efficacy Data ◽

Safety And Efficacy ◽

Anaplastic Lymphoma

Download Full-text

MORPHEUS: A phase Ib/II multi-trial platform evaluating the safety and efficacy of cancer immunotherapy (CIT)-based combinations in patients (pts) with non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.tps9105 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. TPS9105-TPS9105 ◽

Cited By ~ 1

Author(s):

Melissa Lynne Johnson ◽

Benjamin J. Solomon ◽

Mark M. Awad ◽

Byoung Chul Cho ◽

Justin F. Gainor ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Immunotherapy ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Safety And Efficacy ◽

Phase Ib

Download Full-text

Final safety and efficacy data for Asian patients (pts) in the MO19390 (SAiL) trial: First-line bevacizumab (Bv) plus chemotherapy in advanced or recurrent non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e18101 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e18101-e18101

Author(s):

C. Tsai ◽

C. Zhou ◽

G. Jiang ◽

Z. Guan ◽

W. M. Zhao ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Efficacy Data ◽

Safety And Efficacy ◽

Asian Patients

Download Full-text

Safety and efficacy of nivolumab and standard chemotherapy drug combination in patients with advanced non-small-cell lung cancer: a four arms phase Ib study

Annals of Oncology ◽

10.1093/annonc/mdw416 ◽

2016 ◽

Vol 27 (12) ◽

pp. 2242-2250 ◽

Cited By ~ 47

Author(s):

S. Kanda ◽

K. Goto ◽

H. Shiraishi ◽

E. Kubo ◽

A. Tanaka ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Drug Combination ◽

Small Cell ◽

Small Cell Lung ◽

Standard Chemotherapy ◽

Safety And Efficacy ◽

Phase Ib ◽

Chemotherapy Drug

Download Full-text

Abstract B53: Multicenter phase Ib study of the safety and efficacy of palifosfamide plus carboplatin/etoposide (PaCE) in patients with small cell lung cancer or other selected cancers.

10.1158/1535-7163.targ-11-b53 ◽

2011 ◽

Author(s):

Wael A. Harb ◽

Ramaswamy Govindan ◽

William B. Fisher ◽

Jill Y. Buck ◽

Jonathan J. Lewis ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Safety And Efficacy ◽

Phase Ib ◽

Multicenter Phase

Download Full-text

Safety and efficacy of buparlisib (BKM120) and chemotherapy in advanced, squamous non-small cell lung cancer (sqNSCLC): Results from the phase Ib/II BASALT-2 and BASALT-3 studies.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e20522 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e20522-e20522 ◽

Cited By ~ 4

Author(s):

Alex A. Adjei ◽

Jaafar Bennouna ◽

Natasha B. Leighl ◽

Enriqueta Felip ◽

Diego Luigi Cortinovis ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Safety And Efficacy ◽

Phase Ib

Download Full-text

A Study to Investigate the Safety and Efficacy of Atezolizumab in Previously-Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Case Medical Research ◽

10.31525/ct1-nct03922997 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Safety And Efficacy ◽

Previously Treated Patients ◽

Previously Treated

Download Full-text

Faculty Opinions recommendation of Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717964584.793468557 ◽

2013 ◽

Author(s):

Bruno Andreoni ◽

Gianmarco Contino

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Safety And Efficacy ◽

First Line Therapy ◽

Line Therapy

Download Full-text

Lorlatinib Exposure‐Response Analyses for Safety and Efficacy in a Phase 1/2 Trial to Support Benefit–Risk Assessment in Non‐Small Cell Lung Cancer

Clinical Pharmacology & Therapeutics ◽

10.1002/cpt.2228 ◽

2021 ◽

Author(s):

Joseph Chen ◽

Ana Ruiz‐Garcia ◽

Leonard P. James ◽

Gerson Peltz ◽

Holger Thurm ◽

...

Keyword(s):

Lung Cancer ◽

Risk Assessment ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase 1 ◽

Small Cell ◽

Small Cell Lung ◽

Safety And Efficacy ◽

Exposure Response ◽

Benefit Risk Assessment

Download Full-text

Randomized, Double-Blind Phase Ib/III Study of Erlotinib With Ramucirumab or Placebo in Previously Untreated EGFR -Mutant Metastatic Non–Small-Cell Lung Cancer (RELAY): Phase Ib Results

Clinical Lung Cancer ◽

10.1016/j.cllc.2017.11.003 ◽

2018 ◽

Vol 19 (3) ◽

pp. 213-220.e4 ◽

Cited By ~ 7

Author(s):

Martin Reck ◽

Edward B. Garon ◽

Luis Paz-Ares ◽

Santiago Ponce ◽

Jesus Corral Jaime ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Double Blind ◽

Phase Ib ◽

Egfr Mutant

Download Full-text